Pembrolizumab with platinum- and fluoropyrimidine-based chemotherapy for untreated advanced HER2-negative gastric or gastro-oesophageal junction adenocarcinoma
Technology appraisal guidance
Reference number: TA997
Published:
Evidence
Review and download supporting evidence. Includes the full guideline if available.